136 related articles for article (PubMed ID: 7572275)
1. Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survival.
Brenneman DE; Hill JM; Glazner GW; Gozes I; Phillips TW
Int J Dev Neurosci; 1995; 13(3-4):187-200. PubMed ID: 7572275
[TBL] [Abstract][Full Text] [Related]
2. Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide.
Brenneman DE; Neale EA; Foster GA; d'Autremont SW; Westbrook GL
J Cell Biol; 1987 Jun; 104(6):1603-10. PubMed ID: 3584242
[TBL] [Abstract][Full Text] [Related]
3. Cytokine regulation of neuronal survival.
Brenneman DE; Schultzberg M; Bartfai T; Gozes I
J Neurochem; 1992 Feb; 58(2):454-60. PubMed ID: 1729393
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous electrical activity regulates vasoactive intestinal peptide expression in dissociated spinal cord cell cultures.
Agoston DV; Eiden LE; Brenneman DE; Gozes I
Brain Res Mol Brain Res; 1991 Jun; 10(3):235-40. PubMed ID: 1715967
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide and electrical activity influence neuronal survival.
Brenneman DE; Eiden LE
Proc Natl Acad Sci U S A; 1986 Feb; 83(4):1159-62. PubMed ID: 3456568
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen.
Brenneman DE; Nicol T; Warren D; Bowers LM
J Neurosci Res; 1990 Mar; 25(3):386-94. PubMed ID: 2325164
[TBL] [Abstract][Full Text] [Related]
7. A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms.
Brenneman DE; Page SW; Schultzberg M; Thomas FS; Zelazowski P; Burnet P; Avidor R; Sternberg EM
J Pharmacol Exp Ther; 1993 Aug; 266(2):1029-35. PubMed ID: 8355179
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of interleukin-1 beta and interleukin-2 on glia and hippocampal neurons in culture.
Araujo DM; Cotman CW
Int J Dev Neurosci; 1995; 13(3-4):201-12. PubMed ID: 7572276
[TBL] [Abstract][Full Text] [Related]
9. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system.
Gozes I; McCune SK; Jacobson L; Warren D; Moody TW; Fridkin M; Brenneman DE
J Pharmacol Exp Ther; 1991 Jun; 257(3):959-66. PubMed ID: 1646331
[TBL] [Abstract][Full Text] [Related]
10. Structural specificity of peptides influencing neuronal survival during development.
Brenneman DE; Foster GA
Peptides; 1987; 8(4):687-94. PubMed ID: 3628084
[TBL] [Abstract][Full Text] [Related]
11. Regulation of vasoactive intestinal peptide expression in sympathetic neurons in culture and after axotomy: the role of cholinergic differentiation factor/leukemia inhibitory factor.
Sun Y; Rao MS; Zigmond RE; Landis SC
J Neurobiol; 1994 Apr; 25(4):415-30. PubMed ID: 8077967
[TBL] [Abstract][Full Text] [Related]
12. Neurotrophic action of VIP on spinal cord cultures.
Brenneman DE; Eiden LE; Siegel RE
Peptides; 1985; 6 Suppl 2():35-9. PubMed ID: 4080617
[TBL] [Abstract][Full Text] [Related]
13. VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting neuroprotective peptide.
Brenneman DE; Glazner G; Hill JM; Hauser J; Davidson A; Gozes I
Ann N Y Acad Sci; 1998 Dec; 865():207-12. PubMed ID: 9928014
[TBL] [Abstract][Full Text] [Related]
14. Induction by vasoactive intestinal peptide of interferon alpha/beta synthesis in glial cells but not in neurons.
Chelbi-Alix MK; Brouard A; Boissard C; Pelaprat D; Rostene W; Thang MN
J Cell Physiol; 1994 Jan; 158(1):47-54. PubMed ID: 7505279
[TBL] [Abstract][Full Text] [Related]
15. Norepinephrine and vasoactive intestinal peptide induce IL-6 secretion by astrocytes: synergism with IL-1 beta and TNF alpha.
Maimone D; Cioni C; Rosa S; Macchia G; Aloisi F; Annunziata P
J Neuroimmunol; 1993 Aug; 47(1):73-81. PubMed ID: 8376550
[TBL] [Abstract][Full Text] [Related]
16. Antiserum to activity-dependent neurotrophic factor produces neuronal cell death in CNS cultures: immunological and biological specificity.
Gozes I; Davidson A; Gozes Y; Mascolo R; Barth R; Warren D; Hauser J; Brenneman DE
Brain Res Dev Brain Res; 1997 Apr; 99(2):167-75. PubMed ID: 9125470
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide and nitric oxide promote survival of adult rat myenteric neurons in culture.
Sandgren K; Lin Z; Fex Svenningsen A; Ekblad E
J Neurosci Res; 2003 Jun; 72(5):595-602. PubMed ID: 12749024
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide enhances its own expression in sympathetic neurons after injury.
Mohney RP; Zigmond RE
J Neurosci; 1998 Jul; 18(14):5285-93. PubMed ID: 9651211
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation.
Delgado M; Ganea D
FASEB J; 2003 May; 17(8):944-6. PubMed ID: 12626429
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide and corticotropin-releasing hormone increase beta-endorphin release and proopiomelanocortin messenger RNA levels in primary cultures of hypothalamic cells: effects of acute and chronic ethanol treatment.
Poplawski MM; Boyadjieva N; Sarkar DK
Alcohol Clin Exp Res; 2005 Apr; 29(4):648-55. PubMed ID: 15834231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
